Vascular Erectile Dysfunction: Causes and Treatment Options

Vascular erectile dysfunction is the most common physical cause of erection problems, driven by the same blood-vessel damage that underlies heart disease, stroke, and peripheral artery disease. When arteries supplying the penis narrow or the tissue that traps blood during an erection becomes scarred, achieving or maintaining firmness becomes difficult or impossible. Because the penile arteries are smaller than coronary arteries, trouble in the bedroom often shows up years before a heart attack or angina, making ED a potentially useful early-warning signal for broader cardiovascular trouble.

How Blood Vessel Damage Leads to Erection Problems

An erection depends on a rapid surge of blood into the spongy tissue of the penis, followed by a mechanical trapping mechanism that keeps that blood in place. The process starts at the inner lining of the blood vessels, the endothelium, which releases nitric oxide to relax smooth muscle and open the arteries wide. Research has shown that men with ED and no other obvious cardiovascular disease already have measurably impaired endothelial function compared with men without ED, suggesting the problem is systemic rather than confined to the penis.¹

Vascular ED generally falls into two categories. In arteriogenic ED, plaque buildup or arterial stiffness restricts inflow, so not enough blood reaches the erectile tissue. In venogenic ED (sometimes called venous leak), blood enters the penis normally but escapes too quickly because the tissue meant to compress the veins has become fibrotic. Pathology studies have found that this fibrosis is related to excess connective tissue in the erectile bodies, likely driven by chronic low oxygen levels that alter collagen production.² The atherosclerosis that develops with aging reduces oxygen delivery to penile tissue, which in turn leads to loss of smooth muscle cells and a shift in the collagen balance that makes the tissue stiffer and less elastic.³ In many men, arterial and venous problems coexist, creating a double hit.

Why ED Can Signal Future Heart Trouble

The connection between erectile dysfunction and coronary artery disease is one of the most clinically important findings in men’s health over the past two decades. Because the penile arteries are roughly half the diameter of the coronary arteries, a given amount of plaque buildup will obstruct them sooner. Evidence-based guidance from a Princeton consensus panel estimates that ED symptoms typically appear two to three years before coronary artery disease symptoms and three to five years before a cardiovascular event like a heart attack.⁴ A clinical study found that the average time interval between the onset of sexual dysfunction and the diagnosis of coronary artery disease was about 24 months.⁵

ED is now considered an independent risk factor for cardiovascular disease, meaning it raises the odds of heart trouble even after accounting for the usual suspects like high cholesterol and smoking.⁶ The practical takeaway is straightforward: a man who develops erectile problems, especially before age 60 and without an obvious psychological trigger, should get a cardiovascular workup. That window of two to five years before a potential cardiac event is a real opportunity to change course with medication and lifestyle changes.

The Major Risk Factors

The conditions that damage blood vessels elsewhere in the body damage penile blood vessels too. The overlap is almost total.

High Blood Pressure

Hypertension is one of the strongest contributors to vascular ED. Estimates suggest that roughly two-thirds of men with high blood pressure have some degree of erectile difficulty, and the ED in hypertensive men tends to be more severe than in the general population.⁷ The mechanism sits at the endothelium: chronic high pressure batters the vessel lining until it can no longer produce enough nitric oxide to dilate the penile arteries on demand.⁸ To make matters more frustrating, some blood-pressure medications, particularly older thiazide diuretics and certain beta-blockers, can worsen erections as a side effect. If you suspect your blood-pressure pill is contributing, it is worth discussing alternatives with your doctor rather than stopping the medication on your own, since uncontrolled hypertension will do more vascular damage over time.

Diabetes

Diabetes accelerates nearly every mechanism involved in vascular ED. Chronically elevated blood sugar damages endothelial cells, reduces nitric oxide availability, speeds up plaque formation, and causes thickening of tiny blood vessel walls (microangiopathy) that impairs tissue-level blood flow.⁹ Men with diabetes also tend to have lower levels of circulating cells that repair damaged blood vessel linings, which means the damage accumulates faster and heals more slowly. Diabetic ED often appears earlier and progresses more rapidly than ED in men without diabetes, and it tends to respond less well to first-line medications.

Metabolic Syndrome and Obesity

You don’t need a full diabetes diagnosis for metabolic trouble to affect your erections. Metabolic syndrome, the cluster of insulin resistance, abdominal obesity, high triglycerides, low HDL cholesterol, and elevated blood pressure, drives vascular endothelial dysfunction through multiple overlapping pathways. The result is impaired blood-vessel relaxation, progressive scarring of erectile tissue, and reduced blood-flow reserve in the penis.¹⁰ Excess visceral fat also lowers testosterone and raises inflammatory markers, both of which compound the vascular problem.

Smoking

Cigarette smoking damages endothelial cells, promotes arterial stiffness, and reduces nitric oxide production, all directly relevant to erection quality. The relationship is dose-dependent: heavier smokers tend to have worse erectile function. A major long-term cessation study found that erection quality improved in a quarter of men who quit smoking over one year, while none of the men who kept smoking saw improvement.¹¹ Smaller experiments have shown measurable increases in penile blood flow within 24 to 36 hours of quitting, suggesting some vascular recovery begins almost immediately.

High Cholesterol

Elevated LDL cholesterol contributes to atherosclerotic plaque in penile arteries just as it does in coronary arteries. Cholesterol-lowering statins have shown a small but meaningful improvement in erectile function scores across randomized trials, and the benefit was especially notable in men who had not responded well to standard ED pills.¹² The mechanism probably involves improved endothelial nitric oxide availability and reduced oxidative stress. There is a nuance here, though: aggressively lowering LDL below about 100 mg/dL with statins has been associated in some studies with decreased testosterone and potentially worsened erectile function scores, suggesting a U-shaped relationship where moderate cholesterol reduction helps but extreme reduction may have downsides.¹³

How Vascular ED Is Diagnosed

A standard erectile dysfunction evaluation starts with a medical history, a medication review, and basic blood work to check for diabetes, cholesterol problems, and hormone levels. When a vascular cause is suspected, the most common next step is penile duplex Doppler ultrasound, performed after injecting a drug that triggers an erection. The ultrasound measures how fast blood flows into the penile arteries (peak systolic velocity) and how well the veins close down afterward (end-diastolic velocity). Peak flow rates above 35 cm/s are considered normal, rates below 25 cm/s point to arterial insufficiency, and the range between 25 and 35 cm/s is considered equivocal. Venous leak is suspected when outflow velocity stays elevated above 5 cm/s despite adequate inflow.¹⁴

Nocturnal penile tumescence and rigidity (NPTR) testing, which monitors erections during sleep, has traditionally been used to distinguish physical from psychological ED: the reasoning is that if you get firm erections while asleep, the plumbing works and the cause is likely psychological. But this test has limitations. One study found that NPTR could not reliably separate men with underlying endothelial dysfunction from those with normal vascular function, because some men with genuine vascular problems still achieved decent nighttime erections.¹⁵ A positive (normal) NPTR result remains useful for supporting a psychogenic diagnosis, but a negative result should prompt further vascular investigation rather than being taken at face value.¹⁶ Another study found that men with evidence of psychogenic dysfunction on psychological testing could still have abnormal Doppler results, so interpreting any single test in isolation is risky.¹⁷

First-Line Treatment With PDE5 Inhibitors

Oral medications that block the enzyme phosphodiesterase type 5, the class that includes sildenafil, tadalafil, vardenafil, and avanafil, have been the go-to first-line therapy for erectile dysfunction since sildenafil’s approval in 1998. These drugs work by amplifying the nitric oxide signal that relaxes penile smooth muscle: they don’t create an erection on their own but make it easier for sexual stimulation to produce one.¹⁸ On-demand PDE5 inhibitors work for roughly 60 to 70 percent of men with ED overall. That leaves about 30 to 35 percent who don’t get a satisfactory response, and the failure rate is higher in men with severe vascular damage, advanced diabetes, or after radical prostate surgery.¹⁹

Before concluding that a PDE5 inhibitor has truly failed, it is worth checking for common reasons a pill might underperform. These include taking it on a full stomach (which slows absorption for some drugs in the class), not allowing enough time before attempting intercourse, not providing adequate sexual stimulation, or taking too low a dose. Studies estimate that 30 to 50 percent of apparent non-responders can be “salvaged” with proper counseling and dosage adjustment.²⁰ Options for men who have genuinely tried and failed a PDE5 inhibitor include switching to a different drug in the same class, moving to a daily low-dose regimen instead of on-demand dosing, or combining the pill with another therapy like a vacuum device or low-dose alprostadil.

Lifestyle Changes That Actually Help

Because vascular ED shares its root causes with cardiovascular disease, the same lifestyle modifications that protect the heart also protect erectile function. Clinical trials in men with obesity or metabolic syndrome have shown that weight loss, increased physical activity, and dietary improvements can restore erections that had been lost or significantly improve erectile function scores.²¹

A Mediterranean-style diet, high in olive oil, vegetables, fruits, whole grains, nuts, and fish, has been specifically linked to lower risk and reduced severity of ED, with the strongest evidence coming from men with type 2 diabetes. A randomized trial (the MEDITA trial) showed that diabetic patients following a Mediterranean diet experienced a slower decline in sexual function and measurable reductions in inflammatory markers compared with controls.²² The probable explanation is that such a diet improves lipid and glucose metabolism, boosts antioxidant defenses, and raises arginine levels, which the body converts into nitric oxide.

Quitting smoking deserves special emphasis because the vascular benefits begin so quickly. As noted earlier, penile blood flow improves measurably within a day or two of the last cigarette, and long-term quitters have significantly better odds of improved erectile function than men who keep smoking.¹¹ None of these changes work overnight, and a man with advanced atherosclerotic damage will likely still need medication. But lifestyle interventions complement drug therapy and, for some men with early-stage vascular changes, may be enough on their own.

Injectable Therapies When Pills Fall Short

For men who don’t respond to oral medications, the next step is usually intracavernosal injection therapy: a small needle delivers vasodilator drugs directly into the side of the penis. Because the medication acts locally rather than traveling through the whole body, it bypasses the need for a functioning nitric oxide pathway, making it effective even in men with severe vascular damage. Patients report high satisfaction with injections despite the understandable intimidation factor of the needle.²³

The most commonly used single agent is alprostadil (prostaglandin E1), which relaxes smooth muscle by a different biochemical route than PDE5 inhibitors. Clinical evidence shows a positive effect in roughly 60 to 78 percent of men. For those who need more, two- or three-drug mixtures that combine alprostadil with papaverine (a smooth muscle relaxant) and phentolamine (an alpha-blocker that reduces the constriction signal) can produce stronger results by targeting multiple points in the relaxation process simultaneously.²⁴ Alprostadil is also available as a urethral pellet (intraurethral alprostadil), though the injection form tends to be more effective. The main risks of injection therapy include priapism (a prolonged erection requiring medical attention) and scarring at injection sites with long-term use, both manageable with proper technique and dose calibration.

Emerging Approaches

Low-Intensity Shockwave Therapy

Low-intensity extracorporeal shockwave therapy (LI-ESWT) applies acoustic energy pulses to penile tissue with the goal of triggering new blood vessel growth. The idea is that unlike medications, which compensate for vascular damage, shockwave therapy might actually repair it. Preclinical and early clinical data show promise: in one series, 60 to 75 percent of men who had been dependent on PDE5 inhibitors were able to achieve erections and vaginal penetration without pills after treatment, and 72 percent of men who had previously failed PDE5 inhibitors became responders.²⁵ These results are encouraging, but larger randomized trials with longer follow-up are still needed. Treatment protocols, including optimal energy levels, number of sessions, and patient selection, remain unstandardized, which means results can vary widely between clinics.

Platelet-Rich Plasma

Platelet-rich plasma (PRP) therapy involves drawing a patient’s own blood, concentrating the platelets and growth factors, and injecting the resulting preparation into the erectile tissue. The rationale is that these growth factors could stimulate tissue repair and new blood vessel formation. A systematic review identified 16 clinical studies, including two placebo-controlled randomized trials, that showed promising efficacy with no reported adverse events.²⁶ That said, the overall body of evidence is still small, protocols differ widely between studies, and PRP for ED is not yet an approved standard treatment. Men interested in PRP should be cautious about clinics marketing it aggressively without acknowledging these limitations.

Surgical and Device-Based Options

Penile Revascularization

For a specific subset of men, usually younger patients whose arterial blockage resulted from pelvic or perineal trauma (a bicycle accident or a straddle injury, for instance) rather than from systemic atherosclerosis, surgical revascularization can potentially restore natural erectile function. The procedure reroutes an artery to bypass the damaged segment. It is not appropriate for the typical older man with diffuse atherosclerotic disease, where the problem is too widespread for a single bypass to fix.²⁷ In older men with more localized arterial blockages, the procedure has been tried with some reported success, though it remains far less common than medical therapy.²⁸

Pudendal Artery Stenting

An endovascular approach borrowed from cardiac catheterization has emerged for men with focal atherosclerotic narrowing of the internal pudendal artery. A pilot study of 30 men who had a poor response to PDE5 inhibitors placed drug-eluting stents in the pudendal arteries and found that about 60 percent of the intention-to-treat group and 70 percent of per-protocol patients met the primary improvement endpoint at six months, with no major adverse events.²⁹ A separate series used both drug-eluting balloons and stents in 32 patients with clinical success in 31 of them.³⁰ These are small early-stage studies, and questions about long-term durability, restenosis rates, and optimal patient selection remain open. Still, the concept of treating erectile dysfunction the way cardiologists treat blocked coronary arteries is an active and intriguing area of research.

Penile Prostheses

When all else fails, an inflatable penile prosthesis (often called a penile implant) remains the definitive solution. A three-piece inflatable device is surgically placed inside the erectile bodies, with a pump in the scrotum and a fluid reservoir behind the pubic bone. The man squeezes the pump to inflate the cylinders when he wants an erection and presses a release valve when he is done. Long-term data across hundreds of patients show five-year device survival rates in the range of 87 to 93 percent and ten-year rates of roughly 77 percent, with overall satisfaction around 87 percent and over 80 percent of men saying they would choose the procedure again.³¹³²

The most common reasons for device removal over time are mechanical failure, cylinder extrusion, and, less commonly, infection. Rigidity scores are typically the highest-rated aspect of the device, while orgasm rates are lower, reflecting the fact that the prosthesis addresses the mechanical component of erection but does not directly influence sensation or climax. For men with severe vascular ED who have exhausted other options, the prosthesis offers reliable rigidity and consistently high patient satisfaction, which is why it has endured for decades despite the advances in less invasive therapies.

Medications That Can Make Vascular ED Worse

An underappreciated aspect of vascular ED is the role of medications prescribed for the very conditions that caused the problem. Thiazide diuretics and older beta-blockers used for hypertension are the most frequently cited offenders.⁷ Newer antihypertensives, particularly ACE inhibitors and angiotensin receptor blockers, are generally considered more erection-friendly, and some evidence suggests they may even improve endothelial function. If you are taking blood-pressure medication and notice worsening erections, bringing this up at your next appointment is reasonable. Switching drug classes can sometimes make a meaningful difference without compromising blood-pressure control.

The statin picture is more complex. A meta-analysis found that statins modestly improved erectile function scores overall, likely by improving endothelial health and nitric oxide availability.¹² However, because statins block an early step in cholesterol synthesis that is also used to make testosterone, very aggressive LDL lowering has been linked in some research to reduced testosterone and worsened erectile function scores.¹³ The net effect for most men is positive, especially those with high cardiovascular risk. But if erectile function declines noticeably after starting or intensifying statin therapy, testosterone levels are worth checking.

1
PubMed. Is endothelial function impaired in erectile dysfunction patients?
2
PubMed. Mechanisms of venous leakage: a prospective clinicopathological correlation of corporeal function and structure
3
International Journal of Impotence Research. Smooth muscle pathology and erectile dysfunction
4
PubMed. Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus
5
PubMed Central. Association between erectile dysfunction and coronary artery disease and it’s severity
6
PubMed Central. Erectile dysfunction, metabolic syndrome, and cardiovascular risks: facts and controversies
7
International Journal of Impotence Research. Erectile dysfunction and hypertension
8
PubMed Central. Erectile dysfunction and hypertension: impact on cardiovascular risk and treatment
9
Exploration of Cardiology. Vascular and neural mechanisms linking sexual dysfunction and peripheral artery disease in patients with diabetes
10
PubMed Central. Metabolic Syndrome-Associated Erectile Dysfunction: Multiple Vascular Endothelial Dysfunction Mechanisms and Potential Therapeutic Targets
11
Sexual Medicine Reviews. Cigarette smoking and erectile dysfunction: an updated review with a focus on pathophysiology, e-cigarettes, and smoking cessation
12
PubMed Central. The role of statins in erectile dysfunction: a systematic review and meta-analysis
13
PubMed. The effects of statin treatment on adrenal and sexual function and nitric oxide levels in hypercholesterolemic male patients treated with a statin
14
PubMed Central. Diagnostic categorization of erectile dysfunction using duplex color doppler ultrasonography and significance of phentolamine redosing in abolishing false diagnosis of venous leak impotence
15
International Journal of Impotence Research. Abnormal endothelial function in ED patients with normal nocturnal penile tumescence and rigidity: is it the role of psychogenic factors?
16
The Journal of Sexual Medicine. Can a Nocturnal Penile Tumescence and Rigidity Test Detect Organic Aetiology of Erectile Dysfunction? A Peripheral and Penile Vascular Study
17
PubMed. Comparison of duplex ultrasonography and nocturnal penile tumescence in evaluation of impotence
18
PubMed Central. PDE5 inhibitors – pharmacology and clinical applications 20 years after sildenafil discovery
19
PubMed. Non-invasive Management Options for Erectile Dysfunction When a Phosphodiesterase Type 5 Inhibitor Fails
20
PubMed Central. Treatment Strategy for Non-Responders to PDE5 Inhibitors
21
PubMed Central. Lifestyle modifications and erectile dysfunction: what can be expected?
22
PubMed Central. Mediterranean diet and erectile dysfunction: a current perspective
23
PubMed. Intracavernosal Injection for the Diagnosis, Evaluation, and Treatment of Erectile Dysfunction: A Review
24
PubMed Central. Intracavernous Injection Therapy as Second-Line Treatment for ED After Radical Prostatectomy: A Literature Review
25
Sexual Medicine Reviews. Low‐Intensity Extracorporeal Shock Wave Therapy in Vascular Disease and Erectile Dysfunction: Theory and Outcomes
26
Oxford Academic. Platelet-rich plasma for the treatment of erectile dysfunction: a systematic review of preclinical and clinical studies
27
PubMed Central. Penile revascularization–contemporary update
28
PubMed Central. Penile vascular surgery for treating erectile dysfunction: Current role and future direction
29
PubMed. Zotarolimus-eluting peripheral stents for the treatment of erectile dysfunction in subjects with suboptimal response to phosphodiesterase-5 inhibitors
30
Journal of Indian College of Cardiology. Pudendal artery stenting for complex erectile dysfunction in males
31
PubMed Central. Long-term survival and patient satisfaction with inflatable penile prosthesis for the treatment of erectile dysfunction
32
PubMed Central. Excellent long-term device survival of inflatable penile prosthesis over 27 years